2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$40.57+$0.02 (+0.05%)
Price as of Jul 13, 2026 6:18 PM EDT- $2.5BMarket Cap
- 3.36%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$40.57+$0.02 (+0.05%)
AGIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.55 | ||
Change | -$0.68 (-1.65%) | ||
Open | $40.67 | ||
High | $41.10 | ||
Low | $39.43 | ||
Previous Close | $41.23 | ||
Volume | 713,936 | ||
30-Day Average Volume | 1,278,190 | ||
1-Week Change | 8.45% | ||
1-Month Change | 37.64% | ||
1-Year Change | 3.36% | ||
3-Year Change | 45.03% | ||
5-Year Change | -27.71% | ||
Fundamentals | |||
Shares Outstanding | 59.5M | ||
Total Assets | $1.2B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $20.7M | ||
Net Income | -$99.1M | ||
Free Cash Flow | -$119.7M | ||
EBIT | -$99.1M | ||
EBITDA | -$97.7M | ||
Net Working Capital | $776.0M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 113 | ||
P/B | 2 | ||
P/E | -24 | ||
PEG | -3 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue